Some health care workers who are hesitant to get the COVID-19 vaccine are waiting to see what the vaccine does to their colleagues who have gotten it first, a study suggests.
After you, by all means. That seems to be the attitude of some health care workers (HCWs) who are hesitant to get a COVID-19 vaccine for now. You, first. They’re wary because the vaccines were granted under emergency use authorization (EAU) and want to see more data collected over time to ensure their safety, according to investigators with McGill University Faculty of Medicine, Montreal, Canada.
“Our study identified the desire to let other individuals receive the vaccine first as an important reason to decline vaccination,” according to their study in the American Journal of Infection Control (AJIC). Investigators add that the results suggest “that many who hesitate or refuse vaccination initially, could accept vaccination in the future, providing that their reasons for hesitancy are alleviated.”
Investigators surveyed 2761 HCWs at a huge public health care organization in Montreal called Centre Intégré Universitaire de Santé et de Services Sociaux Centre-Ouest-de-Montréal (CIUSSS COMTL) between December 15, 2020 and December 28, 2020. Of that group, 2233 (80.9%) said that they would get vaccinated while 528 (19.1%) said that they would not. The respondents worked in various health care settings including acute care, long term care, rehabilitation, community health, and primary care.
The survey listed 15 possible reasons for not getting the COVID-19 vaccine, and “four (27%) were identified as ‘important’ or ‘very important’ by more than half of those who refused the vaccine,” the study states. “These included: the concern that this vaccine is new (82% agreement); the preference to let other people receive the vaccine first (77% agreement), the lack of available information about the vaccine (74% agreement); and the lack of time to make their decision (60% agreement).”
Some survey respondents said that they did not trust pharmaceutical companies (35%) and health care experts (27%). In addition, a quarter of respondents said that they’d prefer to develop immunity by getting COVID-19 and recovering, rather than through vaccination.
As Infection Control Today® has reported, vaccine hesitancy among HCWs has been a nagging concern, and could be a hindrance to getting society in general to herd immunity. As Kevin Kavanagh, MD, a member of ICT®’s Editorial Advisory Board, put it recently: “It’s hard to convince a patient to become vaccinated when they were just escorted to the room with a nurse who did not have the vaccine.”
That point is made in the AJIC study, as well. Saying that while most HCWs are more willing to be vaccinated against COVID-19 than, for instance, influenza, that’s not a particularly high bar to set. “On average, less than 50% of Canadian HCWs receive the influenza vaccine each year,” the study states.
Investigators said that COVID-19 vaccine promotion campaigns in health care settings might help alleviate hesitancy, especially if they include updated data on safety and efficacy. Also, peer support: Distribution of “I am vaccinated” buttons for HCWs to wear.
“HCWs are not only among the first to be vaccinated in most jurisdictions, but they are also role models for the general public, therefore their acceptance and recommendation may influence hesitant members of the general population to eventually accept vaccination,” the study states. “It is thus crucial that we address barriers to vaccine acceptance in this group. Our findings suggest that providing more information on the safety and efficacy of the new vaccines and promoting positive peer influence could be key in addressing the major concerns of the HCWs who hesitate to be vaccinated.”
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies